|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/506 | (2006.01) |
| A61K 9/48 | (2006.01) | ||
| A61P 7/00 | (2006.01) |
| (11) | Number of the document | 2635282 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11838957.6 |
| Date of filing the European patent application | 2011-11-07 | |
| (97) | Date of publication of the European application | 2013-09-11 |
| (45) | Date of publication and mention of the grant of the patent | 2022-09-28 |
| (46) | Date of publication of the claims translation | 2022-12-12 |
| (86) | Number | PCT/US2011/059643 |
| Date | 2011-11-07 |
| (87) | Number | WO 2012/061833 |
| Date | 2012-05-10 |
| (30) | Number | Date | Country code |
| 410924 P | 2010-11-07 | US |
| (72) |
JAYAN, Arvind , US
CACACE, Janice , US
TEFFERI, Ayalew , US
|
| (73) |
Impact Biomedicines, Inc. ,
86 Morris Avenue, Summit, New Jersey 07901,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Mielofibrozės gydymui skirtos kompozicijos |
| COMPOSITIONS FOR TREATING MYELOFIBROSIS |
| Payment date | Validity (years) | Amount | |
| 2024-10-04 | 14 | 289.00 EUR |
| 2025-11-07 |